Professor Miguel Castanho, principal investigator at Instituto de Medicina Molecular João Lobo Antunes (Lisboa, Portugal) spoke about the rationale behind a drug development strategy to inactivate viruses such as Zika and SARS-CoV-2 in the brain, during the XII Biochemistry Day on April 14, 2021 at University of Aveiro.